Edition:
United States

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

7.27USD
3:59pm EST
Change (% chg)

$-0.27 (-3.58%)
Prev Close
$7.54
Open
$7.52
Day's High
$7.55
Day's Low
$7.19
Volume
1,036,688
Avg. Vol
1,625,231
52-wk High
$17.99
52-wk Low
$5.77

Select another date:

Thu, Nov 16 2017

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK, Nov 16 A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

U.S. asks drug maker Endo to withdraw opioid amid abuse crisis

WASHINGTON As the United States battles a growing opioid abuse crisis, the Food and Drug Administration on Thursday asked Endo International Plc to withdraw from the market its long-lasting opioid painkiller, Opana ER, sending Endo's shares down more than 12 percent.

FDA asks Endo to withdraw Opana ER opioid, shares fall

June 8 The U.S. Food and Drug Administration said on Thursday it has asked Endo International to withdraw from the market its long-lasting opioid painkiller Opana ER, sending the company's shares down as much as 13 percent.

Select another date: